Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.05% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 9.2% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Health Catalyst
HCAT
$139M
| $2.02M | ﹤0.01% |
189,651
-690,414
| -78% | -$6.67M |
|
2852
Advantage Solutions
ADV
$420M
| $2.01M | ﹤0.01% |
38,739
+17,751
| +85% | +$1.12M |
|
|
CTIC
2853
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2M | ﹤0.01% |
333,524
-37,965
| -10% | -$207K |
|
2854
Tiptree Inc
TIPT
$672M
| $1.99M | ﹤0.01% |
144,025
+3,811
| +3% | +$49.1K |
|
2855
CareDx
CDNA
$2.34B
| $1.99M | ﹤0.01% |
174,462
-13,125
| -7% | -$194K |
|
|
ILPT
2856
Industrial Logistics Properties Trust
ILPT
$595M
| $1.98M | ﹤0.01% |
606,946
-298,034
| -33% | -$1.24M |
|
|
GRP.U
2857
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $1.98M | ﹤0.01% |
38,856
-121
| -0.3% | -$6.46K |
|
2858
Vitamin Cottage Natural Grocers
NGVC
$648M
| $1.98M | ﹤0.01% |
216,593
+49,856
| +30% | +$524K |
|
|
GNTY
2859
DELISTED
Guaranty Bancshares
GNTY
| $1.98M | ﹤0.01% |
57,108
+4,115
| +8% | +$146K |
|
|
DX
2860
Dynex Capital
DX
$3.24B
| $1.96M | ﹤0.01% |
153,933
+9,180
| +6% | +$114K |
|
2861
Alector
ALEC
$219M
| $1.95M | ﹤0.01% |
211,778
-11,773
| -5% | -$103K |
|
2862
Castle Biosciences
CSTL
$905M
| $1.95M | ﹤0.01% |
82,982
+1,964
| +2% | +$45.5K |
|
2863
Boston Omaha
BOC
$420M
| $1.95M | ﹤0.01% |
73,455
-26,354
| -26% | -$691K |
|
|
WOW
2864
DELISTED
WideOpenWest
WOW
| $1.94M | ﹤0.01% |
213,452
-126,432
| -37% | -$1.43M |
|
2865
Arcutis Biotherapeutics
ARQT
$3.29B
| $1.94M | ﹤0.01% |
131,373
+6,764
| +5% | +$118K |
|
2866
Bionano Genomics
BNGO
$13.9M
| $1.94M | ﹤0.01% |
2,218
+12
| +0.5% | +$15.1K |
|
2867
BrightView Holdings
BV
$1.09B
| $1.94M | ﹤0.01% |
281,765
+42,369
| +18% | +$327K |
|
2868
Allogene Therapeutics
ALLO
$708M
| $1.94M | ﹤0.01% |
308,422
+19,900
| +7% | +$184K |
|
|
INDT
2869
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $1.94M | ﹤0.01% |
30,548
+8,076
| +36% | +$459K |
|
2870
Intrepid Potash
IPI
$493M
| $1.94M | ﹤0.01% |
67,039
+18,156
| +37% | +$673K |
|
2871
The RMR Group
RMR
$346M
| $1.93M | ﹤0.01% |
68,291
-35,946
| -34% | -$977K |
|
2872
Sutro Biopharma
STRO
$340M
| $1.93M | ﹤0.01% |
23,871
+8,284
| +53% | +$576K |
|
2873
Opko Health
OPK
$1.03B
| $1.93M | ﹤0.01% |
1,540,406
-502,924
| -25% | -$793K |
|
2874
FS KKR Capital
FSK
$3.42B
| $1.92M | ﹤0.01% |
109,948
+17,041
| +18% | +$317K |
|
2875
Life Time Group Holdings
LTH
$10.1B
| $1.92M | ﹤0.01% |
160,813
+8,266
| +5% | +$94.4K |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.